Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (opent nieuw venster)

Arbach O, Funck R, Seibt F, Salama A.

Bron‎: Transfus Med Hemother 2012;39(3):221-3.

Geïndexeerd‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (opent nieuw venster)

The changing spectrum of drug-induced immune hemolytic anemia. (opent nieuw venster)

Arndt PA, Garratty G.

Bron‎: Semin Hematol 2005;42(3):137-44.

Geïndexeerd‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (opent nieuw venster)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (opent nieuw venster)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Bron‎: Blood 2012;119(16):3691-7.

Geïndexeerd‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (opent nieuw venster)

Autoimmune hemolytic anemia. (opent nieuw venster)

Gehrs BC, Friedberg RC.

Bron‎: Am J Hematol 2002;69(4):258-71.

Geïndexeerd‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (opent nieuw venster)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (opent nieuw venster)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Bron‎: Blood 2010;116(23):4783-5.

Geïndexeerd‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (opent nieuw venster)

A case of late-onset systemic lupus erythematosus with severe anemia. (opent nieuw venster)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Bron‎: Kurume Med J 2013;60(1):25-8.

Geïndexeerd‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (opent nieuw venster)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (opent nieuw venster)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Bron‎: Blood 2002;100(2):704-6.

Geïndexeerd‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (opent nieuw venster)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (opent nieuw venster)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Bron‎: Blood 2001;97(12):3995-7.

Geïndexeerd‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (opent nieuw venster)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (opent nieuw venster)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Bron‎: Blood 2003;101(10):3857-61.

Geïndexeerd‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (opent nieuw venster)